2456. Immunogenicity and Safety of a MenACWY-CRM Booster Dose 4–6 Years After Primary Quadrivalent Meningococcal Conjugate Vaccination in Healthy US Adolescents and Adults

BACKGROUND: Neisseria meningitidis serogroups A, B, C, W, and Y are a leading cause of bacterial meningitis and sepsis worldwide. Infants <1 year, adolescents and young adults are at the highest risk. The US Advisory Committee on Immunization Practices (ACIP) recommends routine MenACWY conjugate...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Tipton, Mary, Daly, Wendy, Senders, Shelly, Block, Stanley L, Keshavan, Pavitra, Mzolo, Thembile, Pellegrini, Michele
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254311/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2109
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki